Profiel
Robert Tighe is currently working as Vice President-Research at TCR2 Therapeutics, Inc. He previously worked as VP-Translational Immunology & Immunopharmacology at Compass Therapeutics, Inc.
Actieve functies van Robert Tighe
Bedrijven | Functie | Begin |
---|---|---|
TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Robert Tighe
Bedrijven | Functie | Einde |
---|---|---|
COMPASS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
COMPASS THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |